logo

HITAP เข้าสู่ระบบ

ลืมรหัสผ่าน?

Economic Evaluation of Prime-Boost HIV vaccine (ALVAC-HIV® and AIDSVAX B/E®) for the Thai population (in Thai language)

Home > Research Projects > Strategy 3 : HTA Research > Economic Evaluation of Prime-Boost HIV vaccine (ALVAC-HIV® and AIDSVAX B/E®) for the Thai population (in Thai language)

Project Code

02-302-2552

Research team

Researchers

Pattara Leelahavarong, PhD.

Co - Researcher

Yot Teerawattananon, PhD.

Chutima Akaleephan

Nakor Premsri

Chawetsan Namwat

Pitsaphun Werayingyong

Project Details

Strategies
Category
Support
Project duration

Start: - 2009
End: -

Contact
[email protected]

Project Status

Completed - 100%

Viewer: 1820

Publish date8 December 2011 04:33

Project Summary

A cost-utility analysis was performed to estimate the costs and quality adjusted life year (QALY) of HIV prevention program compared to only existing programs. This analysis focused on both the general population and high risk populations. This study found that the incremental cost effectiveness ratio of HIV vaccination was most sensitive to change in risk behaviors at the post-vaccination period. If postvaccination risk behavior remained unchanged, HIV vaccination for high risk populations would be more cost-effective than for the general population.

Documents

Activity

โครงการประเมินเทคโนโลยีและนโยบายด้านสุขภาพ ชั้น 6 อาคาร 6 กรมอนามัย กระทรวงสาธารณสุข ถ.ติวานนท์ อ.เมือง จ.นนทบุรี 11000

โทร : +662-590-4549 , +662-590-4374-5
โทรสาร : +662-590-4369
E-mail : [email protected]

© Copyright - HITAP 2014
Top